Raymond James Financial Services Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,100
Closed -$372K 3285
2022
Q1
$372K Buy
+7,100
New +$1.09M ﹤0.01% 2555
2021
Q4
Sell
-27,200
Closed -$440K 3335
2021
Q3
$440K Buy
27,200
+10,600
+64% +$1.83M ﹤0.01% 2451
2021
Q2
$226K Buy
16,600
+4,200
+34% +$767K ﹤0.01% 2928
2021
Q1
$30K Buy
+12,400
New +$2.39M ﹤0.01% 3125
2020
Q1
Sell
-11,200
Closed -$10K 2472
2019
Q4
$10K Buy
+11,200
New +$1.67M ﹤0.01% 2827

Other funds holding CLX

Raymond James Financial Services Advisors's CLX Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Clorox (CLX) stake by 4.6% in Q3 2024, selling an estimated $775K and leaving 107,434 shares worth $17.5M. The position accounts for 0.02% of the portfolio, ranked #598.

Raymond James Financial Services Advisors first reported a position in CLX in Q2 2013 and has held it in 38 quarters since. The position peaked at $44.8M in Q2 2020. 1,152 funds tracked by Wall St. Rank hold CLX as of Q3 2024.

  • Raymond James Financial Services Advisors held 107,434 shares of Clorox worth $17.5M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 5,230 Clorox shares in Q3 2024, an estimated $775K.
  • Clorox made up 0.02% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #598 holding.
  • Raymond James Financial Services Advisors first reported a position in Clorox in Q2 2013 and has held it in 38 quarters since.
  • Raymond James Financial Services Advisors's Clorox position peaked at $44.8M in Q2 2020.
  • 1,152 funds tracked by Wall St. Rank held Clorox as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.